Concept Life Sciences is a knowledge-based, science-led contract research organisation providing a wide range of innovative and integrated solutions to clients in the pharmaceutical, biotechnology, food, environmental, agrochemical, petrochemical, chemical and consumer products sectors. Formed as a result of targeted acquisition and organic growth, the Company has the in-house expertise and resource to support customers with projects spanning from target discovery to the clinic, adding value and IP throughout the discovery pathway.
The company employs over 700 FTEs, including more than 500 highly skilled, experienced scientists, supporting its global client base from 11 state of the art laboratory facilities. Having experienced rapid growth, Concept Life Sciences remains focused on problem solving, quality, collaboration, and flexibility
In 2017 Concept Life Sciences acquired Aquila BioMedical. This acquisition represents a pivotal addition to the comprehensive range of integrated services Concept provides, supporting customers throughout the drug discovery and development process
In January 2018, Concept Life Sciences became an Operating Company of Spectris plc.